SCHEMBL13058122

SCHEMBL13058122

O=C(Nc1sc2c(c1-c1nc3ccccc3s1)CCN(Cc1ccccc1)C2)c1cc(Cl)sc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.57
APEX1 P27695 9/20 0.54
KDM4E B2RXH2 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
NPC1 O15118 2/20 0.53
HTT P42858 2/20 0.53
USP2 O75604 2/20 0.53
POLB P06746 1/20 0.53
RECQL P46063 1/20 0.53
RAB9A P51151 1/20 0.53
BLM P54132 1/20 0.53
TP53 P04637 2/20 0.53
UHRF1 Q96T88 2/20 0.51
MAPT P10636 3/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 1/20 0.50
TSHR P16473 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
RXFP1 Q9HBX9 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1494800 0.86 APEX1 (0.73) LMNAAPEX1KDM4EMEN1KMT2A
SCHEMBL1494908 0.85 LMNA (0.59) LMNAAPEX1KDM4EMEN1KMT2A
SCHEMBL1495068 0.85 APEX1 (0.64) LMNAAPEX1KDM4EMEN1KMT2A
SCHEMBL3746827 0.85 LMNA (0.60) LMNAAPEX1KDM4EMEN1KMT2A
SCHEMBL3757276 0.85 MEN1 (0.64) LMNAAPEX1KDM4EMEN1KMT2A
SCHEMBL3754472 0.84 LMNA (0.54) LMNAAPEX1KDM4EMEN1KMT2A
SCHEMBL13058120 0.84 LMNA (0.57) LMNAAPEX1KDM4EMEN1KMT2A
SCHEMBL3800758 0.83 LMNA (0.62) LMNAAPEX1KDM4EMEN1KMT2A
SCHEMBL13833633 0.81 LMNA (0.69) LMNAAPEX1KDM4EMEN1KMT2A
SCHEMBL13058123 0.80 LMNA (0.59) LMNAAPEX1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298370-A1 BENZOTHIAZOLYL THIENOPYRIDINE DERIVATIVES AND USES THEREOF RIMONYX PHARMACEUTICALS LTD. (IL) 2010-11-25 US disclosed
US-20100298370-A1 BENZOTHIAZOLYL THIENOPYRIDINE DERIVATIVES AND USES THEREOF RIMONYX PHARMACEUTICALS LTD. (IL) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298370-A1 BENZOTHIAZOLYL THIENOPYRIDINE DERIVATIVES AND USES THEREOF HPSE, HDGF, HPGDS LMNA 4715/4885APEX1 4756/4885KDM4E 3176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.